LLY
Eli Lilly and Company
$1,229.93
▲ +1.81%
+$21.81
NYSE · Healthcare · Drug Manufacturers - General
Eli Lilly and Company
LLY · NYSE · Healthcare · Drug Manufacturers - General
$1,229.93
▲ +1.81% · +$21.81 today
fundamentals61.7 /100 vs peers
weak
Revenue CAGR (3Y)
No Revenue CAGR (3Y) data
Revenue CAGR (5Y)
No Revenue CAGR (5Y) data
Profit CAGR (3Y)
No Profit CAGR (3Y) data
Profit CAGR (5Y)
No Profit CAGR (5Y) data
Profit CAGR (10Y)
No Profit CAGR (10Y) data
Compared against sector peers where available.
vs sector peers
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| LLYEli Lilly and Company | $1.10T | 43.7 | +47.4% | 62 |
| INDVIndivior | $4.59B | 19.1 | -0.3% | 84 |
| DXCMDexcom | $28.11B | 31.2 | +16.1% | 76 |
| GMEDGlobus Medical | $10.85B | 18.6 | +23.5% | 76 |
| GILDGilead Sciences Inc. | $160.36B | 17.6 | +3.5% | 74 |
